Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America
Jennifer K Quint(Imperial College London), Yvette M. Weesie, Chantal Touboul(Inserm), Ralf J.P. van der Valk(Alexion Pharmaceuticals (United States)), Andrew Fong, Karissa Johnston, Christina Qian, Vicente Plaza(Hospital de Sant Pau), Njira Lugogo(University of Michigan), Joke C. Korevaar, Chantal Rahérison(Inserm), Ileen Gilbert(AstraZeneca (United States)), Keith Peres Da Costa, Sofie Arnetorp(AstraZeneca (Sweden)), Maciej Kupczyk(Karolinska Institutet), Brandie Walker(University of Calgary), Joseph Tkacz, Filip Surmont, Silvia Boarino, Janwillem Kocks(University Medical Center Groningen), Dorota Brzostek, Javier Nuevo(AstraZeneca (Spain)), C. Fabry-Vendrand, Stephen G. Noorduyn, Paul Hernandez(Dalhousie University), Ekaterina Maslova, Erika Penz(University of Saskatchewan), Liset van Dijk(Netherlands Institute for Health Services Research), Michael Pollack, Helena Goike, Hitesh Gandhi, Marcia Vervloet(Netherlands Institute for Health Services Research), Wendy Beekman-Hendricks, Claudia Cabrera(AstraZeneca (Sweden))
Cited by 79
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
|Canadian Respiratory Journal|2007|685
Patient adherence to medical treatment: a review of reviews
|BMC Health Services Research|2007|632
The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature
|Journal of the American Medical Informatics Association|2012|470